It is expected that; with the application of a non-invasive therapy with low intensity laser; which will consist of the systemic photoactivation of the carotid artery and the photobiomodulation of the taste buds and salivary glands; it will present results of reducing the manifestation of dysgeusia as a sequel of the coronavirus (COVID-19).

It is expected that; with the application of a non-invasive therapy with low intensity laser; which will consist of the systemic photoactivation of the carotid artery and the photobiomodulation of the taste buds and salivary glands; it will present results of reducing the manifestation of dysgeusia as a sequel of the coronavirus (COVID-19).